Cycling: de Hartog et al. Respond by de Hartog, Jeroen Johan et al.
A 114  v o l u m e 119 | number 3 | March 2011  •  Environmental Health Perspectives
Perspectives | Correspondence
Cycling: Health Benefits and Risks
doi:10.1289/ehp.1003227
de Hartog et al. (2010) quantified the balance 
between physical activity and air pollution and 
accident risks of cycling and concluded that 
the benefits outweigh the risks by an order of 
magnitude. This is the most comprehensive 
and quantitative comparison to date, based 
on the published data available at the time. In 
the weeks after publication of the article, two 
new relevant studies were published; this illus-
trates that a scientific answer to this question is 
urgent from the societal perspective. In many 
places cyclists are perceived to have a higher 
exposure to air pollution and a higher accident 
risk. Do the new data tilt the balance between 
the risks and benefits of cycling?
de Hartog et al. (2010) used a ventila-
tion rate that is twice as high for cyclists as 
for car drivers. In a recent study in Belgium 
(Int Panis et al. 2010), we found that both 
the ventilation rate and the tidal volume 
were increased and that minute ventilation 
was 4.3 times higher in cyclists compared 
with car passengers (similar to the ratio of 
meta  bo  lic rates). The difference can further 
be explained by differences in cycling speeds 
and lung deposition resulting in a dose that 
is up to 9 times higher in cyclists. 
The life expectancy (LE) loss estimated 
from substituting this ratio into the calcula-
tion by de Hartog et al. (2010) may thus off-
set most of the expected LE gain. However, 
this is unlikely because some studies have 
observed an LE gain in the presence of air 
pollution (Andersen et al. 2000). To resolve 
this conflict, it is important to consider the 
implicit assumptions in the comparison. 
First, the higher dose ratios apply only 
to situations without route choice, although 
cyclists prefer to avoid motorized traffic, 
which exposes them to lower concentrations 
(Zuurbier et al. 2009). Second, an LE loss 
calculation based on long-term studies 
assumes a linear relationship between the 
risk and the daily dose. Exposure to short, 
high bursts of traffic exhaust may be different 
from an exposure to the same dose over a 
longer period. Assuming a linear exposure 
response function leads to over  estimation 
of the impact of peak exposures. Third, 
cyclists are not a random sample from the 
general population. Air pollution mortality 
is often associated with the elderly and 
individuals with cardio  vascular problems, 
but most cyclists are neither old nor very 
likely to suffer from bad health. Also, LE 
loss calculations cannot distinguish between 
situations in which a few people suffer a high 
LE loss or those in which many people have a 
small loss (Rabl 2003). Cyclists are generally 
young and in excellent health and therefore 
less vulnerable, implying that the relative risk 
used by de Hartog et al. (2010) is too high 
for application to this specific population. 
In addition, accidents remain an impor-
tant cause for concern. Aertsens et al. (2010) 
recently estimated the cost of minor bicycle 
accidents at an astonishing 0.12€/km cycled. 
Including the more serious accidents in the 
equation would yield a cost that could easily 
offset the value of the LE benefit calculated 
by de Hartog et al. (2010). 
If the higher LE observed in present day 
cyclists can be transferred to people now taking 
up cycling, the benefits will probably be higher 
than the risks. However, it will be crucial to 
demon  strate that cycling increases physi  cal 
activity. Without increased physical activity 
there are only risks, but reducing those risks 
may yield larger bene  fits than anticipated. 
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We thank Int Panis for his thoughtful com-
ments on our article (de Hartog et al. 2010), 
and we broadly agree with his comments. 
In fact, we discussed most of the issues—
including the limitation to impact on mor-
tality, sensitive subgroups, route choice, and 
activity substitution—in our paper. 
The first issue discussed by Int Panis is 
whether we under  estimated the difference in 
minute ventilation between cyclists and car 
drivers; however, his comment was based 
on a recent Belgian study (Int Panis et al. 
2010) that was not published at the time of 
our study. In our analysis we used a ratio of 
2.2 [the average of two Dutch studies that 
closely agreed (van Wijnen et al. 1995; 
Zuurbier et al. 2009)], whereas the Belgian 
study (Int Panis et al. 2010) found a ratio of 
4.3. The difference is probably explained in 
part by differences in cycling speed: 12 km/hr   
in the recent Dutch study (Zuurbier et al. 
2009) and > 19 km/hr in the Belgian study 
(Int Panis et al. 2010). In urban areas, the aver-
age cycling speed is about 15 km/hr, including 
stop time. Rather than replacing the previous 
estimates by with the newer Belgian estimate, 
we believe that the best current estimate would 
be the average of the ratios of the three avail-
able studies. This would lead to a ratio of 2.9. 
Use of this ratio based on more studies clearly 
would not tip the balance between cycling and 
car driving as Int Panis suggests. We think it is 
stretching the data too much to use deposited 
particle mass (actually 5.9–8.99 higher in the 
Belgian study) for the analysis, because the 
long-term epidemiological studies we used are 
based on concentrations meas  ured in outdoor 
air. In the most likely estimate we provided 
for air pollution [based on black smoke, which 
better represents traffic exposures than PM2.5 
(particulate matter < 2.5 µm in aerodynamic 
diameter)], even including these estimates 
would not make a difference. 
As we noted in the “Discussion” of our 
article (de Hartog et al. 2010), cyclists have 
more opportunity in urban areas to choose 
low-exposure routes. This would indeed 
result in smaller differences in inhaled doses 
between cyclists and car drivers than we used. 
We agree that we may have over  estimated the 
air pollution risks related to cycling because, 
in general, subjects who cycle are healthier 
than those who respond in long-term epide-
miological studies. However, with increasing 
evidence that air pollution—through oxidative 
stress and inflammation—may also increase 
pre  clinical cardio  vascular disease, including 
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athero  sclerosis (Brook et al. 2010), long-
term effects of air pollution are not limited to   
mortality in the most sensitive subjects. 
Another issue deals with the large number 
of non  fatal bicycle accidents reported in 
a recent assessment in Belgium (Aertsens 
et al. 2010). We do not want to downplay 
the importance of these accidents; however, 
because Aertsens et al. (2010) exclusively 
reported accidents in cyclists, the study can-
not be used in a comparative assessment of 
the risks of cyclists and car drivers, the topic 
of our paper. There is therefore no basis for 
Int Panis’s statement that inclusion of this 
information could easily have tipped the bal-
ance between risks and bene  fits. As we dis-
cussed in our article (de Hartog et al. 2010), 
we also did not take into account the bene-
fits of physical activity on quality of life and 
other non  fatal health effects. We welcome an 
attempt to systemati  cally make this assessment. 
In an assessment of traffic accident risks and 
bene  fits from air pollution and physical activity   
in the general population using disability-
adjusted life years (DALYs), Woodcock et al. 
(2009) found that about about 80% of the 
calculated DALYs of all stressors were due to 
loss in life years, so we do not expect our con-
clusion to be much affected when morbidity is 
assessed. Finally, we fully agree with the state-
ments about the importance of reducing risks 
from accidents and air pollution for commut-
ers. Our paper should not be interpreted as a 
plea for ignoring these important risks. 
The authors declare they have no actual or 
potential competing financial interests. 
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